TABLE 2.
Structures of Pyridoxal-6-azoaryl-5-phosphate Derivatives Examined as Antagonists at P2 Receptors
![]() | |||||
---|---|---|---|---|---|
| |||||
Compounda | 2′ | 3′ | 4′ | 5′ | X |
2 | H | H | H | H | CH2O |
3 | SO3H | H | H | H | CH2O |
4 | H | SO3H | H | H | CH2O |
5 | H | H | SO3H | H | CH2O |
6 (PPADS) | SO3H | H | SO3H | H | CH2O |
7 (IsoPPADS) | SO3H | H | H | SO3H | CH2O |
8 | OCH3 | H | H | SO3H | CH2O |
9 | H | COOH | H | H | CH2O |
10 | H | H | COOH | H | CH2O |
11 | COOH | Cl | H | H | CH2O |
12 | Cl | H | H | H | CH2O |
13 | Cl | H | H | SO3H | CH2O |
14 | Cl | H | H | COOH | CH2O |
15 | H | Cl | COOH | H | CH2O |
16 | Cl | H | H | NO2 | CH2O |
17 | NO2 | H | H | NO2 | CH2O |
18 | H | H | NO2 | H | CH2O |
20 | SO3H | H | H | SO3H | CH2 |
21 | Cl | H | H | SO3H | CH2 |
23 | SO3H | H | H | SO3H | CH2CH2 |
24 | Cl | H | H | SO3H | CH2CH2 |
25 | H | H | COOH | H | CH2CH2 |
27 | SO3H | H | H | SO3H | CH=CH |
29 | SO3H | H | H | SO3H | CH2CH2CH2 |
30 | Cl | H | H | SO3H | CH2CH2CH2 |
![]() | |||||
---|---|---|---|---|---|
R1 | R2 | R3 | R4 | R5 | |
32 | H | SO3H | H | SO3H | H |
33 | SO3H | H | SO3H | H | H |
34 | H | SO3H | H | SO3H | SO3H |
Compounds 1 (X=CH2O), 19 (X=CH2), 22 (X=CH2CH2), 26 (X=CH=CH), and 28 (X=CH2CH2CH2), and 31 (X=CH=CHCH2) are non–azo-linked precursors (see Schemes 1 and 2). Compounds 1, 2, 3, 5, 6, 17, and 18 were reported by Lambrecht etal., 1996.